Dr Houman Ashrafian

First-of-a-kind EU approval granted for eosinophilic esophagitis medicine

With its novel approach for addressing a fundamental cause of…

6 November 2024 | By Catherine Eckford (European Pharmaceutical Review)

With its novel approach for addressing a fundamental cause of eosinophilic esophagitis, approval of the biologic marks a potential new standard of care for paediatric patients.